MBM-02 (Tempol) for the Treatment of Glioblastoma Multiforme (GBM)

Clinical trial NCT04874506 · UNKNOWN

Trial details

NCT number: NCT04874506
Sponsor: Matrix Biomed, Inc.
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Glioblastoma Glioblastoma Multiforme

Start date: 2021-06-01
Primary completion: 2023-01-01
Enrollment: 55

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.